Form 483

Carter BloodCare Form 483, 2018-10-26

FDA issued a Form 483 to Carter BloodCare on 2018-10-26 with 4 public-safe observations.

483· Form 483 issuedBiologics4 observations

Carter BloodCare · Frisco, United States · Issued October 26, 2018

Overview

  • 4 public-safe observations are available for this inspection.
  • 4 structured CFR citations are represented.
  • 3 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

26 Oct 2018
21 CFR 606.60(a)

Maintain and clean equipment

Cited by Elmina E Akwo, Nimmy Mathews, Lauren M Lilly

26 Oct 2018
21 CFR 630.10(e)(2)

Additional Medical Assessment Factors

Cited by Elmina E Akwo, Nimmy Mathews, Lauren M Lilly

26 Oct 2018
21 CFR 630.30(a)(2)

Donor health

Cited by Elmina E Akwo, Nimmy Mathews, Lauren M Lilly

26 Oct 2018
21 CFR 640.4(h)

Storage temperatures after collection

Cited by Elmina E Akwo, Nimmy Mathews, Lauren M Lilly

Inspected site

CBCarter BloodCareFrisco, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 606.60(a)Cited across public-safe Form 483 observations1x
21 CFR 630.10(e)(2)Cited across public-safe Form 483 observations1x
21 CFR 630.30(a)(2)Cited across public-safe Form 483 observations1x
21 CFR 640.4(h)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 4 observations

Every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere